DeepMed Research

National Cancer Center Korea

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.ncc.re.kr

Clinical Trials

Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

Phase 3

Conditions: Gastric Cancer

Interventions: Procedure: D2 lymphadenectomy
Procedure: D2 and #14v lymphadenectomy

First Posted Date: 2017-08-29

Last Posted Date: 2020-03-03

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 518

Registration Number: NCT03264807

Locations: 🇰🇷
Dongnam Inst. of Radiological & Medical Sciences, Busan, Gijang-gun, Korea, Republic of
🇰🇷
The Catholic University of Korea, Incheon St. Mary'S Hospital, Incheon, Bupyeong-gu, Korea, Republic of
🇰🇷
National Cancer Center, Gyeonggi-do, Goyang-si, Korea, Republic of

and more 9 locations

Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC

Phase 2

Conditions: Small Cell Lung Cancer Recurrent

Interventions: Drug: Atezolizumab

First Posted Date: 2017-08-25

Last Posted Date: 2022-04-06

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 35

Registration Number: NCT03262454

Locations: 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Pilot Study of Non-exposure Simple Suturing EFTR With Sentinel Lymph Node Navigation for EGC (Senorita3-pilot)

Not Applicable

Conditions: Early Gastric Cancer

Interventions: Procedure: NESS-EFTR

First Posted Date: 2017-07-13

Last Posted Date: 2017-07-13

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 20

Registration Number: NCT03216174

Locations: 🇰🇷
National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)

Phase 2

Conditions: EGFR Positive Non-small Cell Lung Cancer

Interventions: Drug: Erlotinib plus Bevacizumab
Drug: Erlotinib

First Posted Date: 2017-04-24

Last Posted Date: 2022-04-06

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 128

Registration Number: NCT03126799

Locations: 🇰🇷
National Cancer Center, Goyang-Si, Gyeonggi-do, Korea, Republic of

Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection

Not Applicable

Completed

Conditions: Sentinel Lymph Node
Early Gastric Cancer

Interventions: Procedure: Sentinel basin dissection

First Posted Date: 2017-04-21

Last Posted Date: 2025-04-02

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 243

Registration Number: NCT03123042

Locations: 🇰🇷
Bang Wool Eom, Goyang, Gyeonggi-do, Korea, Republic of
🇰🇷
Soonchunhyang University College of Medicine, Bucheon, Korea, Republic of
🇰🇷
Dongnam Institute of Radiological and Medical Science, Busan, Korea, Republic of

and more 6 locations

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

Conditions: Colon Cancer
Breast Cancer
Malignant Lymphoma
Cancer

First Posted Date: 2017-02-23

Last Posted Date: 2017-04-07

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 300

Registration Number: NCT03062072

Locations: 🇰🇷
National Cancer Center, Korea, Goyang, Korea, Republic of
🇰🇷
Seoul National University Boramae Medical Center, Seoul, Korea, Republic of

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Phase 2

Conditions: Urothelial Carcinoma

Interventions: Other: Normal saline
Drug: Intravesical 2000mg/52.6ml gemcitabine instillation

First Posted Date: 2017-02-23

Last Posted Date: 2022-04-14

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 134

Registration Number: NCT03062059

Locations: 🇰🇷
National Cancer Center, Goyang, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of

and more 2 locations

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

Phase 2

Completed

Conditions: Bladder Cancer

Interventions: Drug: intravesical mitomycin-C 40mg/20ml instillation

First Posted Date: 2017-02-23

Last Posted Date: 2023-01-31

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 71

Registration Number: NCT03058757

Locations: 🇰🇷
National Cancer Center, Goyang, Korea, Republic of

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

Active, not recruiting

Conditions: Non Small Cell Lung Cancer

First Posted Date: 2016-12-14

Last Posted Date: 2024-04-04

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 600

Registration Number: NCT02991924

Locations: 🇰🇷
National Cancer Center (NCC) Korea, Goyang, Gyeonggi-do, Korea, Republic of

Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation

Phase 2

Completed

Conditions: Bowel Preparation
Sodium Picosulfate and Magnesium Citrate
Polyethylene Glycol With Ascorbic Acid

Interventions: Drug: sodium picosulfate and magnesium citrate, polyethylene glycol with ascorbic acid

First Posted Date: 2016-12-01

Last Posted Date: 2019-08-28

Lead Sponsor: National Cancer Center, Korea

Target Recruit Count: 142

Registration Number: NCT02979223

Locations: 🇰🇷
Bun Kim, Goyang, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy